Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Pre-Tax Margin Over TimeContracting
Percentile Rank86
3Y CAGR+47.8%
5Y CAGR+137.2%
Studio
Year-over-Year Change

Pre-tax income as a percentage of revenue

3Y CAGR
+47.8%/yr
vs -28.2%/yr prior
5Y CAGR
+137.2%/yr
Recent deceleration
Acceleration
+76.0pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
75.1x
Strong expansion
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM59.29%+3835.7%
20241.51%-96.9%
202348.48%+164.2%
202218.35%-38.6%
202129.89%+3684.3%
20200.79%-99.9%
2019662.31%+860.8%
201868.93%+69.9%
201740.56%+455.3%
20167.30%-